Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy ( TA ‐ TMA )

Documenti analoghi

• Eculizumab is Associated With Increased Infection Rates and Infection Related Mortality in Children With Thrombotic Microangiopathy After HCT
  di: Michelle L. Schoettler, et al.
  Pubblicazione: (2025)
• Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria
  di: Aldo A. Acosta‐Medina, et al.
  Pubblicazione: (2025)
• Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series
  di: Marc Scheen, et al.
  Pubblicazione: (2026)
• JAK inhibitor treatment‐resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?
  di: Maria Chiara Finazzi, et al.
  Pubblicazione: (2024)
• Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders
  di: Maryam Rafati, et al.
  Pubblicazione: (2025)